Regulators around the world have stressed the need for larger clinical trials and a more coordinated approach to tackle the ongoing mpox public health emergency. This year saw cases being reported from 80 countries, including the US, where the first case of the clade I strain of mpox was reported on 15 November.
Tackling Mpox: Global Regulators Call For Larger Trials And Coordinated Pathways
International regulators want developers of new mpox vaccines to consider alternatives to placebo-controlled studies when these are not feasible, such as the use of animal models and immunobridging studies.
